Product NDC: | 0053-7596 |
Proprietary Name: | Vivaglobin |
Non Proprietary Name: | Human Immunoglobulin G |
Active Ingredient(s): | 160 mg/mL & nbsp; Human Immunoglobulin G |
Administration Route(s): | SUBCUTANEOUS |
Dosage Form(s): | SOLUTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0053-7596 |
Labeler Name: | CSL Behring LLC |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | BLA125115 |
Marketing Category: | BLA |
Start Marketing Date: | 20060109 |
Package NDC: | 0053-7596-20 |
Package Description: | 1 VIAL, SINGLE-USE in 1 CARTON (0053-7596-20) > 20 mL in 1 VIAL, SINGLE-USE |
NDC Code | 0053-7596-20 |
Proprietary Name | Vivaglobin |
Package Description | 1 VIAL, SINGLE-USE in 1 CARTON (0053-7596-20) > 20 mL in 1 VIAL, SINGLE-USE |
Product NDC | 0053-7596 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Human Immunoglobulin G |
Dosage Form Name | SOLUTION |
Route Name | SUBCUTANEOUS |
Start Marketing Date | 20060109 |
Marketing Category Name | BLA |
Labeler Name | CSL Behring LLC |
Substance Name | HUMAN IMMUNOGLOBULIN G |
Strength Number | 160 |
Strength Unit | mg/mL |
Pharmaceutical Classes | Human Immunoglobulin G [EPC],Passively Acquired Immunity [PE],Antigen Neutralization [MoA],Immunoglobulins [Chemical/Ingredient] |